---
title: "The beauty and personal care sector has strengthened again, JIEYA has hit the 20% daily limit up"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/240271373.md"
description: "36Kr has learned that as of the time of publication, the beauty and personal care sector has strengthened again, with JIEYA hitting a 20% limit up, Lafang approaching the limit up, and JAHEN, SYG, Marubi, and Shanghai Jahwa also following suit"
datetime: "2025-05-15T02:12:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/240271373.md)
  - [en](https://longbridge.com/en/news/240271373.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/240271373.md)
generator: "portal-rs"
---

# The beauty and personal care sector has strengthened again, JIEYA has hit the 20% daily limit up

36Kr has learned that as of the time of publication, the beauty and personal care sector has strengthened again, with JIEYA hitting the 20cm limit up, Lafang approaching the limit up, and JAHEN, SYG, Marubi, and Shanghai Jahwa also following suit

### Related Stocks

- [301108.CN](https://longbridge.com/en/quote/301108.CN.md)
- [300740.CN](https://longbridge.com/en/quote/300740.CN.md)
- [603983.CN](https://longbridge.com/en/quote/603983.CN.md)
- [600315.CN](https://longbridge.com/en/quote/600315.CN.md)
- [603630.CN](https://longbridge.com/en/quote/603630.CN.md)
- [300955.CN](https://longbridge.com/en/quote/300955.CN.md)

## Related News & Research

- [EXPLAINER-Haiti's conflict in numbers as gangs inflict another night of terror](https://longbridge.com/en/news/297076683.md)
- [08:17 ETVICTORY HOME REMODELING RISES TO BECOME NATION'S 27TH BEST PLACE TO WORK AND TOP 35 REMODELERS](https://longbridge.com/en/news/297184693.md)
- [MSC halts Russian Black Sea service after drone attack, Bloomberg News reports](https://longbridge.com/en/news/297066548.md)
- [03:12 ETOmdia H1 2026: Hisense Ranks No. 1 Globally in 100-Inch-and-Above TV Shipments](https://longbridge.com/en/news/297138716.md)
- [Heidelberg Pharma says China NMPA clears HDP-101 combo trial in multiple myeloma](https://longbridge.com/en/news/297070749.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**